ArticleScientific reports2019

Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE*3Leiden.CETP mice.

Susanne Schuster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.